ABOUT
Action Potential Venture Capital (APVC) was launched by GSK in 2013 as a corporate venture fund for bioelectronic medicines, announced as a US$50Mn fund located in Cambridge, Massachusetts. Its portfolio includes Exo, a handheld medical imaging company.
PORTFOLIO · 1 COMPANY
Companies Action Potential Venture Capital (GSK) is known to have backed. Round details are not on ExitStack yet.
See something wrong? Suggest a correction.
